Skip to main content

Table 1 Characteristic of patients undergoing HoLEP

From: Preoperative predictors of enucleation time during en bloc ‘no-touch’ holmium laser enucleation of the prostate

Characteristic Data
Total patients, n 135
Age (year), mean (SD) 71.7 (9.3)
History of 5ARi use, n (%) 21 (16)
Requiring Foley catheter at the time of HoLEP, n (%) 14 (10.3)
History of UTI, n (%) 12 (9)
History of anticoagulation, n (%) 13 (10)
Pre-HoLEP PSA (ng/mL), mean (range) 6.2 (0.07–1380)
Previous TURP, n (%) 12 (9)
TRUS-P volume (g), mean (SD) 71.1 (42.8)
 < 50 ml, n (%) 51 (37.7)
 50–80 ml, n (%) 51 (37.7)
 > 80 ml, n (%) 33 (24.4)
  1. 5ARi 5-alpha-reductase inhibitor, HoLEP holmium laser enucleation of the prostate, PSA prostate-specific antigen, SD standard deviation, TRUS-P transrectal ultrasound of the prostate, UTI urinary tract infection